The pharmaceutical industry and its Republican allies in Congress are openly signaling their plans obstruct at every turn as the Biden administration looks to begin implementing a recently passed law that will allow Medicare to negotiate drug prices for the first time in its history. In November, Sen. Marco Rubio (R-Fla.) and several other Republican senators introduced legislation that would…
This post was originally published on Latest – Truthout.